TriSalus Life Sciences, Inc. (TLSIW)

Latest Insider Confidence Score

2025Q4

52.6
Bullish

Company insider confidence (by quarter)

2024Q4 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Frankenius Equity AB 10% Owner 6,230,748 Dec 19, 2024
Matlin David J — 941,944 Jan 6, 2025
Szela Mary T CEO 465,348 Feb 19, 2025
Patience David — 290,000 Aug 15, 2025
Desai Arjun JJ Director 247,127 Dec 12, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 28, 2025 Aug 29, 2025 Patience David CFO Neutral 52.5 - 0.00% ✗ -
Aug 14, 2025 Aug 15, 2025 Patience David CFO Neutral 90.0 +200,000 100.00% ✗ -
Jul 10, 2025 Patience David CFO Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 27, 2025 Desai Arjun JJ Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 27, 2025 Gordon Gary B. Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 27, 2025 HICKS KERRY R Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 27, 2025 MATLIN DAVID J Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 27, 2025 Murphy Sean Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 27, 2025 Valle William Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2025 Jun 27, 2025 Wahlstrom Mats Director Neutral 52.5 - 0.00% ✗ -
May 19, 2025 May 21, 2025 Young James Emmett CFO Neutral 90.0 +13,175 19.82% ✗ -
May 19, 2025 May 21, 2025 Cox Bryan F. Chief of Research Sell 91.3 +10,958 10.10% ✗ $24.7K
May 19, 2025 May 21, 2025 Devlin Jodi Chief of Clinical Operations Sell 91.3 +19,367 57.99% ✗ $24.7K
May 19, 2025 May 21, 2025 Marshak Richard Chief Commercial Officer Sell 91.3 +14,831 27.33% ✗ $34.2K
May 19, 2025 May 21, 2025 Murphy Sean Director Neutral 85.0 +44,884 7.08% ✗ -
May 19, 2025 May 21, 2025 Stevens Jennifer Chief Regulatory Officer Sell 91.3 +19,751 34.12% ✗ $45.1K
Feb 18, 2025 Feb 19, 2025 Murphy Sean Chief Manuf, Strategy&Bus Dev. Neutral 82.5 +15,817 2.56% ✗ -
Feb 18, 2025 Feb 19, 2025 Young James Emmett CFO Neutral 90.0 +14,762 28.54% ✗ -
Feb 18, 2025 Feb 19, 2025 Stevens Jennifer CHIEF REGULATORY OFFICER Neutral 90.0 +14,481 33.36% ✗ -
Feb 18, 2025 Feb 19, 2025 Cox Bryan F. CHIEF OF RESEARCH Neutral 90.0 +11,450 11.80% ✗ -
Feb 18, 2025 Feb 19, 2025 Marshak Richard Chief Commercial Officer Neutral 90.0 +7,644 16.39% ✗ -
Feb 18, 2025 Feb 19, 2025 Szela Mary T CEO Neutral 82.5 +21,089 4.75% ✗ -
Feb 18, 2025 Feb 19, 2025 Devlin Jodi Chief of Clinical Operations Neutral 90.0 +5,272 18.74% ✗ -
Feb 10, 2025 Feb 11, 2025 MATLIN DAVID J Director Neutral 52.5 - 0.00% ✗ -
Feb 10, 2025 Feb 11, 2025 Wahlstrom Mats Director Neutral 52.5 - 0.00% ✗ -
Feb 10, 2025 Feb 11, 2025 Frankenius Equity AB 10% Owner Neutral 52.5 - 0.00% ✗ -
Feb 5, 2025 Feb 6, 2025 Young James Emmett CFO Buy 91.3 +6,000 13.12% ✗ $33.9K
Jan 29, 2025 Jan 31, 2025 Gordon Gary B. Director Neutral 52.5 - 0.00% ✗ -
Jan 31, 2025 Gordon Gary B. Director Neutral 52.5 - 0.00% ✗ -
Jan 29, 2025 Jan 31, 2025 Valle William Director Neutral 52.5 - 0.00% ✗ -
Jan 31, 2025 Valle William Director Neutral 52.5 - 0.00% ✗ -
Jan 29, 2025 Jan 31, 2025 Szela Mary T CEO Buy 82.5 +10,040 2.31% ✗ $51.8K
Jan 27, 2025 Jan 29, 2025 Szela Mary T CEO Buy 95.0 +49,542 12.88% ✗ $50.3K
Jan 27, 2025 Jan 29, 2025 Murphy Sean Chief Manuf, Strategy&Bus Dev. Buy 90.0 +42,500 7.38% ✗ $157.2K
Jan 27, 2025 Jan 29, 2025 Cox Bryan F. CHIEF OF RESEARCH Neutral 90.0 +10,625 12.30% ✗ -
Jan 27, 2025 Jan 29, 2025 Young James Emmett CFO Buy 95.0 +36,500 395.62% ✗ $129.6K
Jan 27, 2025 Jan 29, 2025 Devlin Jodi Chief of COMMERC. OPERATIONS Neutral 90.0 +10,625 60.71% ✗ -
Jan 27, 2025 Jan 29, 2025 Marshak Richard Chief Commercial Officer Neutral 90.0 +12,500 36.63% ✗ -
Jan 27, 2025 Jan 29, 2025 Stevens Jennifer CHIEF REGULATORY OFFICER Neutral 90.0 +10,625 32.41% ✗ -
Jan 15, 2025 Young James Emmett CFO Neutral 52.5 - 0.00% ✗ -
Jan 2, 2025 Jan 6, 2025 MATLIN DAVID J Director Neutral 77.5 +10,040 1.08% ✗ -
Jan 2, 2025 Jan 6, 2025 Hyveled Liselotte Director Neutral 90.0 +10,040 100.00% ✗ -
Oct 5, 2024 Dec 19, 2024 Cox Bryan F. CHIEF SCIENTIFIC & MANUFACT. Sell 52.5 -314 -0.36% ✗ $1.4K
Dec 17, 2024 Dec 19, 2024 Wahlstrom Mats Director Neutral 67.5 +25,188 0.95% ✗ -
Dec 17, 2024 Dec 19, 2024 Frankenius Equity AB 10% Owner Buy 82.5 +62,972 1.02% ✗ $250K
Dec 10, 2024 Dec 12, 2024 Desai Arjun JJ Director Sell 22.5 -30,000 -10.83% ✗ $110.7K
Nov 22, 2024 Nov 25, 2024 Wahlstrom Mats Director Buy 56.3 +5,000 0.19% ✗ $22.8K
Nov 20, 2024 Nov 22, 2024 Wahlstrom Mats Director Buy 61.3 +10,727 0.41% ✗ $47.1K
Nov 14, 2024 Nov 15, 2024 Marshak Richard SR.VP, CORP. DEV. & STRATEGY Neutral 90.0 +6,875 25.23% ✗ -